Aevi Genomic Medicine (Formerly Known As Medgenics)
435 Devon Park Drive
Suite 715
Wayne
Pennsylvania
19087
United States
Tel: 610-254-4201
Website: http://www.aevigenomics.com/
193 articles about Aevi Genomic Medicine (Formerly Known As Medgenics)
-
Medgenics, Inc. To Present At The Oppenheimer 24th Annual Healthcare Conference
12/4/2013
-
Medgenics, Inc. Reports Sale Of Common Stock By Director
12/4/2013
-
Medgenics, Inc. Reports Open Market Purchase Of Common Stock By Chairman Of The Board
12/3/2013
-
Medgenics, Inc. Reports Third Quarter Financial Results
11/7/2013
-
Medgenics, Inc. to Host Business Update Conference Call on Friday, November 8th at 8:30 a.m. Eastern Time
11/4/2013
-
Medgenics, Inc. to Present Poster at European Society of Gene and Cell Therapy Congress to Highlight Results from Second-Generation Viral Vector
10/23/2013
-
Medgenics, Inc. to Present Poster at European Society of Gene and Cell Therapy Congress to Highlight Results from Second-Generation Viral Vector
10/23/2013
-
Medgenics, Inc. Appoints Biopharmaceutical Industry Veteran Bill Gantz to its Board of Directors
10/17/2013
-
Medgenics, Inc. Reports Second Quarter Financial Results
8/6/2013
-
Medgenics, Inc. Awarded $1.9 Million Grant From the Israeli Office of the Chief Scientist
7/9/2013
-
Medgenics, Inc. to Present at the 8th Annual JMP Securities Healthcare Conference
7/8/2013
-
Medgenics, Inc. Reports First Quarter 2013 Financial Results
5/9/2013
-
Medgenics, Inc. Announces Results of 2013 Annual Meeting of Stockholders
5/1/2013
-
Medgenics, Inc. Reports "Encouraging" Data From Epodure Biopump Trial
4/25/2013
-
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins
4/22/2013
-
Medgenics, Inc. to Present at the 12th Annual Needham Healthcare Conference
4/18/2013
-
Medgenics, Inc. Announces Exercise by Underwriters of Over-Allotment Option
3/26/2013
-
Medgenics, Inc. to Present at the 25th Annual Roth Conference
3/15/2013
-
Medgenics, Inc. Reports 2012 Financial Results
3/14/2013
-
Medgenics, Inc. Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment
1/30/2013